Is this you? Create Your Porfile
Avatar

Kevin P. Anderson

Isis Pharmaceuticals

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Kevin P. Anderson is active.

Explore More

Publication

Featured researches published by Kevin P. Anderson.

Archive | 1996

Antisense inhibition of hepatitis B virus replication

Kevin P. Anderson; Lex M. Cowsert

Antimicrobial Agents and Chemotherapy | 1996

Inhibition of human cytomegalovirus immediate-early gene expression by an antisense oligonucleotide complementary to immediate-early RNA.

Kevin P. Anderson; Maureen Fox; Vickie Brown-Driver; M J Martin; Raana F. Azad

Archive | 1993

Compositions and methods for treatment of hepatitis c virus-associated diseases

Kevin P. Anderson; Ronnie C. Hanecak; Chikateru Nozaki

Archive | 1996

Antisense inhibition of ICAM-1, E-selectin, and CMV IE1/IE2

Brenda F. Baker; C. Frank Bennett; Kevin P. Anderson

Nucleic Acids Research | 1993

Rational screening of oligonucleotide combinatorial libraries for drug discovery

David J. Ecker; Timothy A. Vickers; Ronnie C. Hanecak; Vickie Diver; Kevin P. Anderson

Archive | 1991

Oligonucleotide therapies for modulating the effects of herpes viruses

Kenneth G. Draper; Stanley T. Crooke; Christopher K. Mirabelli; David J. Ecker; Ronnie C. Hanecak; Kevin P. Anderson; Vickie Brown-Driver; Jacqueline R. Wyatt

Antimicrobial Agents and Chemotherapy | 1999

Antisense Oligonucleotide Inhibition of Hepatitis C Virus (HCV) Gene Expression in Livers of Mice Infected with an HCV-Vaccinia Virus Recombinant

Hong Zhang; Ronnie C. Hanecak; Vickie Brown-Driver; Raana F. Azad; Boyd Conklin; Maureen Fox; Kevin P. Anderson

Archive | 1991

Oligonucleotides for modulating the effects of cytomegalovirus infections

Kevin P. Anderson; Kenneth G. Draper; Brenda F. Baker

Antimicrobial Agents and Chemotherapy | 1998

Human Cytomegalovirus Mutant with Sequence-Dependent Resistance to the Phosphorothioate Oligonucleotide Fomivirsen (ISIS 2922)

Gilbert B. Mulamba; André Hu; Raana F. Azad; Kevin P. Anderson; Donald M. Coen

Archive | 1993

Oligonucleotides having a conserved G4 core sequence

Ronnie C. Hanecak; Kevin P. Anderson; C. Frank Bennett; Ming-Yi Chiang; Vickie Brown-Driver; David J. Ecker; Timothy A. Vickers; Jacqueline R. Wyatt; Jean Louis Impasse Des Lucques Imbach

Explore More

Collaboration

Dive into the Kevin P. Anderson's collaboration.

Top Co-Authors
Avatar

David J. Ecker

Isis Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Ronnie C. Hanecak

Isis Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Vickie Brown-Driver

Isis Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Jacqueline R. Wyatt

University of California

View shared research outputs
Top Co-Authors
Avatar

C. Frank Bennett

Isis Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Kenneth G. Draper

Isis Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Timothy A. Vickers

Isis Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Brenda F. Baker

Isis Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Ming-Yi Chiang

Isis Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Jean Louis Impasse Des Lucques Imbach

Isis Pharmaceuticals

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge